Skip to search form
Skip to main content
Skip to account menu
Semantic Scholar
Semantic Scholar's Logo
Search 225,220,273 papers from all fields of science
Search
Sign In
Create Free Account
BMY 28100
Known as:
BMY-28100
National Institutes of Health
Create Alert
Alert
Related topics
Related topics
3 relations
Cefprozil:Susc:Pt:Isolate:OrdQn:MIC
Broader (2)
Cephalosporins
cefprozil
Papers overview
Semantic Scholar uses AI to extract papers important to this topic.
1990
1990
Phase I study of single-dose BMY-28100, a new oral cephalosporin
R. Barbhaiya
,
C. Gleason
,
W. Shyu
,
R. Wilber
,
R. Martin
,
K. Pittman
Antimicrobial Agents and Chemotherapy
1990
Corpus ID: 20689038
The objective of this Phase I study was to evaluate the safety, tolerance, and pharmacokinetics of BMY-28100 in 36 male subjects…
Expand
1990
1990
[General pharmacology of BMY-28100].
A. Goto
,
M. Amano
,
A. Sakai
,
M. Hara
,
N. Takahashi
The Japanese Journal of Antibiotics
1990
Corpus ID: 219024
General pharmacological properties of BMY-28100, a new semisynthetic oral cephalosporin, were studied in experimental animals…
Expand
1990
1990
Pharmacokinetics of cefprozil in infants and children
Xavier Sáez-Llorens
,
W. C. Shyu
,
S. Shelton
,
H. Kumiesz
,
John D. Nelson
Antimicrobial Agents and Chemotherapy
1990
Corpus ID: 809158
Twenty pediatric patients (ages, between 8 months and 8 years) received a single oral dose of cefprozil at levels of 15 and 30 mg…
Expand
1988
1988
In vitro activity of BMY-28100, a new oral cephalosporin.
C. W. Norden
,
K. Niederriter
Chemotherapy
1988
Corpus ID: 3287265
BMY-28100 is a new orally absorbed cephalosporin whose in vitro activity was compared with that of cefaclor. BMY-28100 was more…
Expand
1987
1987
In vitro activity of BMY-28100 against common isolates from pediatric infections
R. Scribner
,
M. Marks
,
B. D. Finkhouse
,
F.
,
Leitner
Antimicrobial Agents and Chemotherapy
1987
Corpus ID: 9269247
The antibacterial activity of BMY-28100, a new oral cephalosporin, was measured against 300 bacterial isolates from pediatric…
Expand
1987
1987
Synthesis and structure-activity relationships of a new oral cephalosporin, BMY-28100 and related compounds.
T. Naito
,
H. Hoshi
,
+4 authors
H. Kawaguchi
Journal of antibiotics (Tokyo. )
1987
Corpus ID: 24304932
The synthesis and structure-activity relationships of 7-[D-alpha-amino-alpha-(4-hydroxyphenyl)-acetamido]-3-[(Z)-1-propenyl]- 3…
Expand
1987
1987
In vitro and in vivo evaluations of BMY-28100, a new oral cephalosporin.
K. Tomatsu
,
Shigeyuki Ando
,
+4 authors
H. Kawaguchi
Journal of antibiotics (Tokyo. )
1987
Corpus ID: 26363376
A new semisynthetic oral cephalosporin, BMY-28100, was evaluated for in vitro and in vivo antibacterial activities in comparison…
Expand
1987
1987
Comparative in vitro activity of the new oral cephalosporin BMY-28100
K. Aldridge
,
D. Schiro
,
C. Sanders
European Journal of Clinical Microbiology
1987
Corpus ID: 7431230
Using a broth microdilution method, the in vitro activity of BMY-28100 against 365 clinical strains of commonly isolated bacteria…
Expand
1987
1987
Disk diffusion susceptibility testing and broth microdilution quality control guidelines for BMY-28100, a new orally administered cephalosporin
Ronald N. Jones
,
A. Barry
Journal of Clinical Microbiology
1987
Corpus ID: 24910107
The BMY-28100 30-micrograms-disk test was evaluated by using 615 clinical isolates. Regression analyses and error rates were…
Expand
1987
1987
In vitro activity and beta-lactamase stability of the oral cephalosporin BMY-28100
M. Hiraoka
,
S. Masuyoshi
,
K. Tomatsu
,
Matsuhisa Inoue
,
S. Mitsuhashi
European Journal of Clinical Microbiology
1987
Corpus ID: 2970938
BMY-28100 was compared with cephalexin, cefaclor, cefixime, and cefteram and found to be more active than the reference…
Expand
By clicking accept or continuing to use the site, you agree to the terms outlined in our
Privacy Policy
(opens in a new tab)
,
Terms of Service
(opens in a new tab)
, and
Dataset License
(opens in a new tab)
ACCEPT & CONTINUE
or Only Accept Required